Mohini - Interview 56
![](/uploads/media/interview/.thumbnails/fileyvzOii_205x410.png)
More about me...
Mohini is 12 years of age and was diagnosed with acute lymphoblastic leukemia at the age of 9. Approximately one year later, her parents were asked by the consultant if they would be willing to enter Mohini in a clinical trial. Mohini was unaware of this at the time; however, her parents discussed it with her at home. They didn’t have to make a decision straight away and discussed together some of the risks and the benefits of taking part.
Mohini says that her parents wanted the decision to be hers. They felt that because it was her life and her future; it was important she had the final call and they would support her in whatever decision she made. They discussed together and Mohini also spoke to some other family members.
After much thought and talking with her parents and other family members, Mohini decided to decline to take part.
Her message to health professionals and those who are recruiting young people to take part in clinical trials is to talk to the young people and not just parents.
She would consider taking part in future clinical trials if they didn’t involve more tablets or medication. She says she has had so many toxins in her body and doesn’t really want any more. However, if it involved talking about experiences and sharing views and completing questionnaires, she would be more than willing to help.
Mohini thought randomisation was quite a risky strategy, but once the consultant explained it, she felt better and able to make an informed decision on whether to take part or not.
Mohini thought randomisation was quite a risky strategy, but once the consultant explained it, she felt better and able to make an informed decision on whether to take part or not.
For some trials, a payment may be appropriate says Mohini, but for many trials knowing that taking part may change your life and make you better is payment enough.
For some trials, a payment may be appropriate says Mohini, but for many trials knowing that taking part may change your life and make you better is payment enough.
Mohini is pleased to know that the results of the trial are now published and a leukaemia treatment used in Europe and the US is now being used for patients in the UK.
Mohini is pleased to know that the results of the trial are now published and a leukaemia treatment used in Europe and the US is now being used for patients in the UK.
Doctors and nurses need to talk to young people says Mohini and not just their parents. A close relationship with staff caring for you is important.
Doctors and nurses need to talk to young people says Mohini and not just their parents. A close relationship with staff caring for you is important.
Mohini says that taking part in a trial that involves intensive treatment is a real commitment to helping other young people in the future. It's important to know that all drugs have had preliminary testing before being trialled in young people.
Mohini says that taking part in a trial that involves intensive treatment is a real commitment to helping other young people in the future. It's important to know that all drugs have had preliminary testing before being trialled in young people.
Mohini feels that doctors need to understand that when young people have to take lots of medicines because of their health, taking more medicines may be just too much.
Mohini feels that doctors need to understand that when young people have to take lots of medicines because of their health, taking more medicines may be just too much.
As a result of a clinical trial, a treatment for leukaemia used in Europe and the USA is now being used for patients in the UK.
As a result of a clinical trial, a treatment for leukaemia used in Europe and the USA is now being used for patients in the UK.
Although Mohini understands about clinical trials, it can be hard to explain what it means to others.
Although Mohini understands about clinical trials, it can be hard to explain what it means to others.
Mohini thought it was a bit unfair that her parents got all the information first.
Mohini thought it was a bit unfair that her parents got all the information first.
She says young people can understand complex information and doctors shouldn't underestimate their intelligence.
She says young people can understand complex information and doctors shouldn't underestimate their intelligence.
It's important young people of all ages are given the opportunity to give their consent to take part, or not, in a clinical trial, says Mohini.
It's important young people of all ages are given the opportunity to give their consent to take part, or not, in a clinical trial, says Mohini.
Making the decision about whether to take part in a trial was not easy. Mohini decided not to take part because she wanted the standard treatment.
Making the decision about whether to take part in a trial was not easy. Mohini decided not to take part because she wanted the standard treatment.
Having time to make a decision about taking part in a trial was helpful to Mohini and she was pleased her parents gave her the final decision.
Having time to make a decision about taking part in a trial was helpful to Mohini and she was pleased her parents gave her the final decision.
Mohini's mum and dad had different views about whether she should take part, but knowing that her parents supported her decision not to take part was important.
Mohini's mum and dad had different views about whether she should take part, but knowing that her parents supported her decision not to take part was important.
Even though it may have been better for Mohini to take part in the trial, she has no regrets about her decision.
Even though it may have been better for Mohini to take part in the trial, she has no regrets about her decision.